Healthcare Sector Stocks
The Healthcare sector has a total of 1054 stocks, with a combined market cap of $9.52 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.75.
Market Cap
9.52T
Revenue
4.67T
Profits
187.63B
PE Ratio
50.75
Profit Margin
4.02%
Dividend Yield
0.37%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -0.04% | 2,307,011 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 670.99B | 1.17% | 5,684,769 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 459.82B | -0.58% | 2,754,643 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 375.85B | 0.46% | 6,281,549 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 359.88B | 0.32% | 4,413,105 | 450.53B |
| 6 | NVS | Novartis AG | 309.14B | 0.39% | 2,452,954 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 250.86B | 1.94% | 2,425,094 | 61.37B |
| 8 | AMGN | Amgen Inc. | 240.11B | 0.29% | 1,717,813 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 228.66B | 1.63% | 1,745,347 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 207.41B | 1.58% | 8,748,364 | 50.34B |
| 11 | ABT | Abbott Laboratories | 188.25B | -1.52% | 5,128,849 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 187.51B | 1.08% | 4,485,444 | 30.46B |
| 13 | PFE | Pfizer Inc. | 164.21B | -0.72% | 25,235,310 | 63.70B |
| 14 | DHR | Danaher Corporation | 148.35B | 0.53% | 2,350,736 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 141.42B | 0.22% | 797,506 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 139.09B | 0.64% | 6,100,483 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 130.65B | -0.55% | 1,355,898 | 11.03B |
| 18 | CVS | CVS Health Corporation | 124.32B | -0.03% | 4,718,959 | 412.65B |
| 19 | MDT | Medtronic plc | 119.17B | 1.00% | 7,346,029 | 37.54B |
| 20 | SYK | Stryker Corporation | 118.14B | -1.35% | 2,154,230 | 25.84B |
| 21 | MCK | McKesson Corporation | 107.42B | -0.37% | 558,012 | 410.98B |
| 22 | SNY | Sanofi | 106.20B | -0.30% | 2,404,353 | 55.89B |
| 23 | GSK | GSK plc | 101.24B | 0.85% | 2,442,155 | 44.05B |
| 24 | ELV | Elevance Health, Inc. | 89.95B | 2.20% | 1,130,302 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 88.59B | 1.78% | 1,037,829 | 78.01B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 84.22B | -1.00% | 495,063 | 15.53B |
| 27 | CI | The Cigna Group | 75.64B | 1.21% | 1,294,027 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 68.04B | -2.94% | 16,033,324 | 21.00B |
| 29 | ARGX | argenx SE | 66.32B | -0.18% | 210,432 | 5.32B |
| 30 | COR | Cencora, Inc. | 64.35B | 0.26% | 1,080,404 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.63B | 1.52% | 2,853,622 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 59.43B | -1.29% | 13,228,919 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 57.82B | 1.27% | 1,382,597 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 51.75B | -1.15% | 1,316,976 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.11B | 0.05% | 1,141,711 | 22.48B |
| 36 | HUM | Humana Inc. | 48.82B | 1.38% | 776,532 | 145.68B |
| 37 | MDLN | Medline Inc. | 48.11B | 0.80% | 5,757,077 | 29.94B |
| 38 | NTRA | Natera, Inc. | 47.23B | 0.77% | 548,191 | 2.71B |
| 39 | VEEV | Veeva Systems Inc. | 46.04B | 1.30% | 1,503,504 | 3.46B |
| 40 | RVMD | Revolution Medicines, Inc. | 45.20B | 0.78% | 1,111,027 | - |
| 41 | IQV | IQVIA Holdings Inc. | 44.71B | 2.95% | 1,947,162 | 16.98B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 42.67B | -2.32% | 3,618,040 | 17.32B |
| 43 | HLN | Haleon plc | 42.64B | -0.50% | 16,892,241 | 14.80B |
| 44 | A | Agilent Technologies, Inc. | 42.28B | -0.93% | 2,197,309 | 7.37B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 41.70B | -1.80% | 583,803 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 41.24B | 0.25% | 120,894 | 6.13B |
| 47 | WAT | Waters Corporation | 40.63B | 0.33% | 433,398 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 36.73B | 1.22% | 2,761,220 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.39B | -1.08% | 1,638,613 | 4.80B |
| 50 | ALC | Alcon Inc. | 35.31B | -0.22% | 845,898 | 10.86B |
| 51 | DXCM | DexCom, Inc. | 33.85B | 0.02% | 1,563,145 | 4.97B |
| 52 | CNC | Centene Corporation | 33.60B | 1.01% | 3,570,037 | 180.30B |
| 53 | ILMN | Illumina, Inc. | 33.47B | 3.94% | 1,707,094 | 4.49B |
| 54 | BIIB | Biogen Inc. | 33.17B | 0.83% | 549,659 | 10.03B |
| 55 | RMD | ResMed Inc. | 33.06B | -0.73% | 751,730 | 5.65B |
| 56 | ZTS | Zoetis Inc. | 31.52B | 0.16% | 2,506,002 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.49B | -1.19% | 3,042,781 | 21.27B |
| 58 | INSM | Insmed Incorporated | 27.66B | 0.04% | 1,884,274 | 1.14B |
| 59 | MTD | Mettler-Toledo International Inc. | 27.17B | -0.84% | 168,334 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 26.88B | -0.05% | 510,976 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.42B | -0.58% | 1,030,246 | 11.56B |
| 62 | INCY | Incyte Corporation | 25.95B | -0.64% | 900,291 | 5.82B |
| 63 | PHG | Koninklijke Philips N.V. | 25.90B | -1.21% | 873,304 | 20.18B |
| 64 | BNTX | BioNTech SE | 25.84B | -0.90% | 1,162,337 | 3.03B |
| 65 | ROIV | Roivant Sciences Ltd. | 24.86B | 0.67% | 6,152,837 | 7.53M |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.12B | 0.03% | 241,434 | 3.33B |
| 67 | STE | STERIS plc | 22.12B | -1.53% | 286,375 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 21.61B | -1.24% | 1,075,216 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 21.22B | 1.92% | 867,619 | 21.81B |
| 70 | UTHR | United Therapeutics Corporation | 21.03B | -0.36% | 469,383 | 3.15B |
| 71 | GMAB | Genmab A/S | 20.40B | 0.57% | 890,944 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.46B | -0.88% | 7,997,374 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.87B | -0.58% | 922,963 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.81B | 1.43% | 1,014,301 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.56B | 0.06% | 143,038 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.10B | 0.35% | 675,842 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 16.07B | 0.81% | 507,494 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.74B | 0.59% | 784,203 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.74B | -1.42% | 1,096,334 | 713.07M |
| 80 | EXEL | Exelixis, Inc. | 14.65B | 1.03% | 1,939,938 | 2.44B |
| 81 | RVTY | Revvity, Inc. | 14.58B | -0.24% | 1,779,311 | 2.91B |
| 82 | CRL | Charles River Laboratories International, Inc. | 14.00B | 0.54% | 646,345 | 4.00B |
| 83 | COO | The Cooper Companies, Inc. | 13.78B | 1.31% | 1,783,296 | 4.23B |
| 84 | SMMT | Summit Therapeutics Inc. | 13.67B | 17.33% | 14,861,562 | - |
| 85 | BAX | Baxter International Inc. | 13.22B | -0.51% | 4,666,443 | 11.47B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.86B | -0.81% | 1,428,100 | 3.41B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.80B | 1.96% | 2,098,848 | 14.37B |
| 88 | PEN | Penumbra, Inc. | 12.65B | -0.51% | 133,598 | 1.50B |
| 89 | ICLR | ICON Public Limited Company | 12.62B | 2.34% | 594,039 | 8.29B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.57B | 1.00% | 1,719,954 | 1.66B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.54B | -0.79% | 112,465 | 1.28B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.22B | 1.31% | 1,366,680 | 669.50M |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.20B | -1.05% | 5,923,537 | 5.02B |
| 94 | CORT | Corcept Therapeutics Incorporated | 12.19B | 2.15% | 604,838 | 830.81M |
| 95 | EHC | Encompass Health Corporation | 12.09B | 1.16% | 759,677 | 6.21B |
| 96 | SNN | Smith & Nephew plc | 12.07B | 0.10% | 1,382,481 | 6.30B |
| 97 | FMS | Fresenius Medical Care AG | 11.89B | -0.79% | 648,091 | 22.19B |
| 98 | TEM | Tempus AI, Inc. | 11.67B | 4.39% | 4,493,988 | 1.43B |
| 99 | DVA | DaVita Inc. | 11.58B | 1.27% | 642,270 | 14.01B |
| 100 | TECH | Bio-Techne Corporation | 11.36B | 0.21% | 2,501,731 | 1.22B |
| 101 | ALGN | Align Technology, Inc. | 11.36B | 0.44% | 694,071 | 4.14B |
| 102 | KRYS | Krystal Biotech, Inc. | 11.00B | 0.61% | 226,444 | 440.48M |
| 103 | AXSM | Axsome Therapeutics, Inc. | 10.91B | -0.75% | 558,114 | 776.57M |
| 104 | ABVX | ABIVAX Société Anonyme | 10.78B | 2.66% | 879,097 | 5.67M |
| 105 | GKOS | Glaukos Corporation | 10.63B | 0.46% | 610,183 | 612.84M |
| 106 | MOH | Molina Healthcare, Inc. | 10.57B | 0.14% | 384,356 | 42.47B |
| 107 | GMED | Globus Medical, Inc. | 10.49B | -3.15% | 1,400,501 | 3.14B |
| 108 | PODD | Insulet Corporation | 10.44B | 1.65% | 926,796 | 3.05B |
| 109 | BIO | Bio-Rad Laboratories, Inc. | 10.37B | -0.16% | 146,268 | 2.59B |
| 110 | CYTK | Cytokinetics, Incorporated | 10.28B | 2.81% | 1,545,236 | 67.67M |
| 111 | AVTR | Avantor, Inc. | 10.27B | 3.69% | 9,318,568 | 6.56B |
| 112 | APGE | Apogee Therapeutics, Inc. | 10.19B | - | - | - |
| 113 | RDY | Dr. Reddy's Laboratories Limited | 10.18B | -1.15% | 3,099,481 | 3.50B |
| 114 | HSIC | Henry Schein, Inc. | 10.13B | 0.52% | 679,334 | 13.60B |
| 115 | UHS | Universal Health Services, Inc. | 9.97B | 1.03% | 463,189 | 18.11B |
| 116 | ENSG | The Ensign Group, Inc. | 9.95B | -0.35% | 253,533 | 5.49B |
| 117 | OSCR | Oscar Health, Inc. | 9.94B | 6.30% | 4,784,434 | 15.32B |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 9.92B | -0.66% | 200,737 | 7.46M |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.75B | -1.14% | 591,463 | 105.00M |
| 120 | IONS | Ionis Pharmaceuticals, Inc. | 9.66B | -5.22% | 3,725,467 | 874.09M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.63B | 1.86% | 353,885 | 281.99M |
| 122 | RGEN | Repligen Corporation | 9.57B | -1.93% | 1,325,271 | 785.10M |
| 123 | PCVX | Vaxcyte, Inc. | 9.10B | -0.67% | 736,462 | - |
| 124 | QGEN | Qiagen N.V. | 9.07B | -0.77% | 1,349,483 | 2.10B |
| 125 | BRKR | Bruker Corporation | 9.05B | 0.66% | 1,195,278 | 3.50B |
| 126 | IBRX | ImmunityBio, Inc. | 8.68B | 3.02% | 4,544,049 | 165.79M |
| 127 | TXG | 10x Genomics, Inc. | 8.24B | 2.55% | 2,170,586 | 616.91M |
| 128 | HQY | HealthEquity, Inc. | 8.17B | 0.24% | 443,406 | 1.36B |
| 129 | ATR | AptarGroup, Inc. | 8.16B | -1.55% | 339,978 | 3.93B |
| 130 | IMVT | Immunovant, Inc. | 8.08B | -0.94% | 1,194,967 | - |
| 131 | TWST | Twist Bioscience Corporation | 8.07B | -1.75% | 1,063,400 | 431.80M |
| 132 | TGTX | TG Therapeutics, Inc. | 8.04B | -0.33% | 1,571,164 | 799.54M |
| 133 | ALKS | Alkermes plc | 7.86B | -1.76% | 641,044 | 1.67B |
| 134 | SYRE | Spyre Therapeutics, Inc. | 7.69B | 0.23% | 1,010,170 | - |
| 135 | HNGE | Hinge Health, Inc. | 7.32B | -1.19% | 1,299,752 | 720.06M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.22B | -0.50% | 269,768 | 239.92M |
| 137 | CAI | Caris Life Sciences, Inc. | 7.16B | 2.10% | 6,399,626 | 989.61M |
| 138 | GRFS | Grifols, S.A. | 6.91B | 0.64% | 434,784 | 8.48B |
| 139 | BLTE | Belite Bio, Inc | 6.89B | 6.49% | 200,880 | - |
| 140 | CHE | Chemed Corporation | 6.83B | 0.09% | 120,633 | 2.60B |
| 141 | PACS | PACS Group, Inc. | 6.82B | -0.05% | 570,224 | 5.55B |
| 142 | SRRK | Scholar Rock Holding Corporation | 6.81B | -0.29% | 802,717 | - |
| 143 | MMED | MiniMed Group, Inc. | 6.70B | 0.34% | 3,783,256 | 3.22B |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.17% | 546,666 | 1.56B |
| 145 | CGON | CG Oncology, Inc. | 6.59B | -0.35% | 359,311 | 6.23M |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | 0.80% | 453,009 | 618.07M |
| 147 | HIMS | Hims & Hers Health, Inc. | 6.49B | -3.00% | 12,039,064 | 2.58B |
| 148 | BLCO | Bausch + Lomb Corporation | 6.48B | 0.78% | 256,432 | 5.32B |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.28B | 0.73% | 620,743 | 840.85M |
| 150 | TVTX | Travere Therapeutics, Inc. | 6.27B | -1.03% | 1,114,896 | 591.33M |
| 151 | AMRX | Amneal Pharmaceuticals, Inc. | 6.22B | -1.05% | 2,732,616 | 3.12B |
| 152 | LQDA | Liquidia Corporation | 6.14B | -1.51% | 770,726 | 450.91M |
| 153 | COGT | Cogent Biosciences, Inc. | 6.07B | 1.10% | 1,014,675 | - |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 6.03B | 1.52% | 355,688 | 1.90M |
| 155 | ORKA | Oruka Therapeutics, Inc. | 6.02B | -0.70% | 724,558 | - |
| 156 | PTCT | PTC Therapeutics, Inc. | 5.96B | -0.54% | 654,519 | 1.01B |
| 157 | TFX | Teleflex Incorporated | 5.93B | -0.72% | 617,945 | 2.25B |
| 158 | RDNT | RadNet, Inc. | 5.87B | -1.43% | 1,006,359 | 2.27B |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.85B | 0.40% | 471,674 | 7.50M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 5.78B | 0.98% | 150,206 | 290.54M |
| 161 | ERAS | Erasca, Inc. | 5.69B | -0.67% | 3,092,264 | - |
| 162 | STVN | Stevanato Group S.p.A. | 5.61B | -0.92% | 168,963 | 1.40B |
| 163 | CRSP | CRISPR Therapeutics AG | 5.46B | -0.76% | 1,467,694 | 13.39M |
| 164 | SHC | Sotera Health Company | 5.43B | 0.37% | 2,278,622 | 1.22B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.29B | -1.73% | 539,221 | 1.58B |
| 166 | DFTX | Definium Therapeutics, Inc. | 5.11B | -2.31% | 1,529,136 | - |
| 167 | PBLS | Parabilis Medicines, Inc. | 5.02B | 1.35% | 408,270 | 148.00K |
| 168 | WAY | Waystar Holding Corp. | 5.00B | 1.40% | 1,418,386 | 1.21B |
| 169 | LFST | LifeStance Health Group, Inc. | 4.90B | -0.47% | 4,162,910 | 1.58B |
| 170 | DOCS | Doximity, Inc. | 4.83B | 2.96% | 1,795,459 | 655.57M |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | 4.80B | -3.70% | 1,849,194 | 1.14B |
| 172 | CELC | Celcuity Inc. | 4.72B | 0.24% | 768,713 | - |
| 173 | BLLN | BillionToOne, Inc. | 4.70B | 3.48% | 639,235 | 397.41M |
| 174 | HAE | Haemonetics Corporation | 4.68B | -0.07% | 602,058 | 1.35B |
| 175 | DYN | Dyne Therapeutics, Inc. | 4.66B | -0.76% | 1,453,467 | - |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.56B | -0.07% | 898,740 | - |
| 177 | LIVN | LivaNova PLC | 4.47B | -1.46% | 694,071 | 1.47B |
| 178 | NVST | Envista Holdings Corporation | 4.43B | 0.73% | 2,331,571 | 2.86B |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.40B | 1.41% | 841,482 | 2.29B |
| 180 | ELVN | Enliven Therapeutics, Inc. | 4.37B | 1.08% | 796,949 | - |
| 181 | HTFL | HeartFlow, Inc. | 4.32B | -0.58% | 1,096,665 | 212.07M |
| 182 | ITGR | Integer Holdings Corporation | 4.27B | 0.15% | 653,520 | 1.84B |
| 183 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.26B | -1.54% | 1,369,100 | -665.00K |
| 184 | LEGN | Legend Biotech Corporation | 4.21B | -0.64% | 1,306,605 | 1.27B |
| 185 | RLAY | Relay Therapeutics, Inc. | 4.17B | 2.70% | 2,630,978 | 10.35M |
| 186 | ICUI | ICU Medical, Inc. | 4.16B | -2.10% | 241,539 | 2.16B |
| 187 | INDV | Indivior Pharmaceuticals, Inc. | 4.11B | -0.63% | 1,312,899 | 1.33B |
| 188 | MANE | Veradermics, Incorporated | 4.08B | -0.72% | 355,526 | - |
| 189 | IRTC | iRhythm Holdings, Inc. | 4.07B | 0.77% | 430,056 | 825.34M |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.98B | 2.53% | 139,703 | 890.79M |
| 191 | VKTX | Viking Therapeutics, Inc. | 3.96B | 1.43% | 1,369,397 | - |
| 192 | IOVA | Iovance Biotherapeutics, Inc. | 3.94B | 0.93% | 10,129,854 | 324.97M |
| 193 | ADPT | Adaptive Biotechnologies Corporation | 3.92B | -0.36% | 2,157,839 | 308.08M |
| 194 | PLSE | Pulse Biosciences, Inc. | 3.90B | 3.85% | 701,664 | 1.19M |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.86B | -0.50% | 567,887 | 234.13M |
| 196 | TNGX | Tango Therapeutics, Inc. | 3.84B | 1.97% | 1,131,305 | 53.81M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.84B | 0.94% | 681,691 | 117.00M |
| 198 | ABCL | AbCellera Biologics Inc. | 3.75B | 1.85% | 3,280,943 | 66.17M |
| 199 | OPCH | Option Care Health, Inc. | 3.66B | 2.56% | 1,536,827 | 5.69B |
| 200 | TARS | Tarsus Pharmaceuticals, Inc. | 3.65B | 0.54% | 733,653 | 606.33M |
| 201 | DNLI | Denali Therapeutics Inc. | 3.64B | -0.22% | 1,727,974 | 3.60M |
| 202 | OGN | Organon & Co. | 3.62B | - | 3,296,995 | 6.13B |
| 203 | GRAL | GRAIL, Inc. | 3.60B | 0.07% | 320,435 | 165.26M |
| 204 | VCYT | Veracyte, Inc. | 3.59B | -0.47% | 502,252 | 561.90M |
| 205 | NHC | National HealthCare Corporation | 3.47B | 1.98% | 77,616 | 1.56B |
| 206 | GPCR | Structure Therapeutics Inc. | 3.38B | -0.96% | 506,656 | - |
| 207 | RGC | Regencell Bioscience Holdings Limited | 3.21B | 2.69% | 414,466 | - |
| 208 | QURE | uniQure N.V. | 3.11B | -2.96% | 1,299,523 | 18.67M |
| 209 | CLDX | Celldex Therapeutics, Inc. | 3.09B | -0.28% | 416,412 | 158.00K |
| 210 | NAMS | NewAmsterdam Pharma Company N.V. | 3.09B | 1.02% | 581,329 | 7.12M |
| 211 | IMNM | Immunome, Inc. | 3.08B | -0.62% | 795,881 | 4.02M |
| 212 | IRON | Disc Medicine, Inc. | 3.05B | -0.85% | 343,202 | - |
| 213 | ZLAB | Zai Lab Limited | 3.03B | 1.96% | 531,577 | 449.61M |
| 214 | TMDX | TransMedics Group, Inc. | 3.02B | 3.19% | 574,667 | 668.47M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.98B | 3.33% | 2,283,045 | 2.60B |
| 216 | ARQT | Arcutis Biotherapeutics, Inc. | 2.97B | -0.80% | 1,122,144 | 463.98M |
| 217 | MBX | MBX Biosciences, Inc. | 2.96B | 0.87% | 292,495 | - |
| 218 | BEAM | Beam Therapeutics Inc. | 2.94B | 0.58% | 1,265,316 | 156.04M |
| 219 | WRBY | Warby Parker Inc. | 2.88B | -2.59% | 1,985,069 | 911.61M |
| 220 | BKD | Brookdale Senior Living Inc. | 2.85B | 0.17% | 3,625,536 | 2.93B |
| 221 | ALHC | Alignment Healthcare, Inc. | 2.81B | -0.33% | 4,100,205 | 4.58B |
| 222 | SLS | SELLAS Life Sciences Group, Inc. | 2.77B | -3.25% | 5,467,490 | - |
| 223 | ATAI | AtaiBeckley Inc. | 2.72B | -0.14% | 17,475,705 | 4.47M |
| 224 | ATRC | AtriCure, Inc. | 2.67B | -0.25% | 1,169,058 | 569.62M |
| 225 | ACHC | Acadia Healthcare Company, Inc. | 2.64B | 2.27% | 1,150,149 | 3.37B |
| 226 | PRVA | Privia Health Group, Inc. | 2.64B | -0.24% | 2,266,180 | 2.36B |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.63B | -1.94% | 1,152,985 | 36.77M |
| 228 | NKTR | Nektar Therapeutics | 2.61B | 4.99% | 691,138 | 54.59M |
| 229 | WGS | GeneDx Holdings Corp. | 2.61B | 0.77% | 484,229 | 454.43M |
| 230 | VRDN | Viridian Therapeutics, Inc. | 2.60B | 0.79% | 1,192,531 | 71.13M |
| 231 | CDNA | CareDx, Inc. | 2.58B | 0.52% | 636,353 | 458.09M |
| 232 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.58B | -0.79% | 1,973,739 | 940.61M |
| 233 | PGEN | Precigen, Inc. | 2.56B | 1.85% | 2,187,205 | 85.72M |
| 234 | SUPN | Supernus Pharmaceuticals, Inc. | 2.56B | -0.14% | 304,096 | 830.44M |
| 235 | GRDN | Guardian Pharmacy Services, Inc. | 2.54B | 2.79% | 572,957 | 1.46B |
| 236 | NEOG | Neogen Corporation | 2.54B | -1.44% | 928,105 | 870.40M |
| 237 | AXGN | Axogen, Inc. | 2.53B | -2.48% | 951,249 | 251.17M |
| 238 | BHC | Bausch Health Companies Inc. | 2.53B | -1.02% | 2,059,749 | 10.85B |
| 239 | VERA | Vera Therapeutics, Inc. | 2.52B | -1.88% | 747,949 | - |
| 240 | PHVS | Pharvaris N.V. | 2.50B | 1.39% | 356,893 | - |
| 241 | MLYS | Mineralys Therapeutics, Inc. | 2.50B | -2.65% | 1,323,767 | - |
| 242 | PBH | Prestige Consumer Healthcare Inc. | 2.49B | -0.51% | 449,100 | 1.10B |
| 243 | HRMY | Harmony Biosciences Holdings, Inc. | 2.44B | -2.33% | 1,100,267 | 959.90M |
| 244 | TRVI | Trevi Therapeutics, Inc. | 2.43B | 0.06% | 1,427,939 | - |
| 245 | SRPT | Sarepta Therapeutics, Inc. | 2.43B | -0.95% | 2,765,141 | 1.97B |
| 246 | BHVN | Biohaven Ltd. | 2.40B | 1.08% | 2,257,259 | - |
| 247 | NUVB | Nuvation Bio Inc. | 2.38B | -2.31% | 5,264,690 | 169.90M |
| 248 | OCUL | Ocular Therapeutix, Inc. | 2.34B | -2.39% | 2,127,697 | 52.06M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.31B | 2.57% | 2,076,834 | 1.14B |
| 250 | RAPP | Rapport Therapeutics, Inc. | 2.29B | -2.14% | 276,731 | 20.00M |
| 251 | KOD | Kodiak Sciences Inc. | 2.28B | -3.04% | 387,730 | - |
| 252 | XRAY | DENTSPLY SIRONA Inc. | 2.28B | 1.24% | 3,924,503 | 3.64B |
| 253 | CLOV | Clover Health Investments, Corp. | 2.26B | -1.05% | 2,096,233 | 2.48B |
| 254 | NEO | NeoGenomics, Inc. | 2.24B | 0.34% | 2,217,548 | 766.30M |
| 255 | PVLA | Palvella Therapeutics, Inc. | 2.24B | 1.65% | 249,660 | - |
| 256 | UFPT | UFP Technologies, Inc. | 2.22B | -2.02% | 150,108 | 631.64M |
| 257 | MESO | Mesoblast Limited | 2.22B | -0.87% | 86,062 | 120.25M |
| 258 | URGN | UroGen Pharma Ltd. | 2.19B | 1.04% | 445,295 | 188.73M |
| 259 | ADUS | Addus HomeCare Corporation | 2.17B | 0.44% | 240,432 | 1.48B |
| 260 | ESTA | Establishment Labs Holdings Inc. | 2.15B | -3.50% | 280,291 | 245.82M |
| 261 | ADMA | ADMA Biologics, Inc. | 2.15B | 0.74% | 1,325,119 | 512.28M |
| 262 | ZBIO | Zenas BioPharma, Inc. | 2.15B | -0.63% | 411,897 | 1.00M |
| 263 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -1.04% | 752,553 | 311.51M |
| 264 | MD | Pediatrix Medical Group, Inc. | 2.13B | 0.07% | 489,248 | 1.95B |
| 265 | ZYME | Zymeworks Inc. | 2.12B | -3.70% | 605,060 | 37.13M |
| 266 | ALMR | Alamar Biosciences, Inc. | 2.12B | 0.26% | 206,971 | 100.42M |
| 267 | HCM | HUTCHMED (China) Limited | 2.11B | 17.19% | 503,512 | 549.12M |
| 268 | GENB | Generate Biomedicines, Inc. | 2.10B | 0.37% | 963,385 | 26.48M |
| 269 | COAG | Hemab Therapeutics Holdings, Inc. | 2.07B | -0.74% | 257,208 | - |
| 270 | VCEL | Vericel Corporation | 2.07B | -1.03% | 213,309 | 306.30M |
| 271 | NVCR | NovoCure Limited | 2.05B | -1.07% | 613,284 | 699.19M |
| 272 | PGNY | Progyny, Inc. | 2.04B | 1.22% | 708,295 | 1.31B |
| 273 | KLRA | Kailera Therapeutics, Inc. | 2.04B | -0.69% | 642,521 | - |
| 274 | NBTX | Nanobiotix S.A. | 2.01B | -4.01% | 97,032 | 38.27M |
| 275 | PRGO | Perrigo Company plc | 1.98B | -1.52% | 1,873,643 | 4.14B |
| 276 | XNCR | Xencor, Inc. | 1.98B | -1.04% | 1,293,796 | 104.97M |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -2.93% | 516,029 | 98.34M |
| 278 | BFLY | Butterfly Network, Inc. | 1.94B | -4.08% | 3,286,748 | 112.14M |
| 279 | KARD | Kardigan, Inc. | 1.94B | -5.38% | 262,834 | - |
| 280 | VIR | Vir Biotechnology, Inc. | 1.94B | -0.43% | 2,564,087 | 303.23M |
| 281 | ASTH | Astrana Health, Inc. | 1.94B | -1.92% | 380,273 | 3.84B |
| 282 | STOK | Stoke Therapeutics, Inc. | 1.94B | -1.67% | 389,814 | 27.59M |
| 283 | IMCR | Immunocore Holdings plc | 1.93B | 0.54% | 245,971 | 430.78M |
| 284 | ALVO | Alvotech | 1.92B | 0.75% | 672,455 | 494.61M |
| 285 | GHRS | GH Research PLC | 1.92B | -0.53% | 116,963 | - |
| 286 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.91B | -0.14% | 2,756,581 | 208.78M |
| 287 | LKFT | Lakefront Biotherapeutics NV | 1.89B | 0.73% | 394,298 | 1.13B |
| 288 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | -0.48% | 1,920,595 | 252.25M |
| 289 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | 1.78% | 13,600,363 | 54.86M |
| 290 | LMAT | LeMaitre Vascular, Inc. | 1.84B | -1.51% | 239,982 | 262.43M |
| 291 | CMPS | COMPASS Pathways plc | 1.84B | 0.45% | 1,694,123 | - |
| 292 | SGRY | Surgery Partners, Inc. | 1.84B | 1.36% | 1,634,171 | 3.37B |
| 293 | FRNM | Freenome, Inc. | 1.82B | 5.96% | 906,439 | 35.41M |
| 294 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | -1.24% | 1,874,008 | 5.49M |
| 295 | INBX | Inhibrx Biosciences, Inc. | 1.80B | -2.17% | 151,713 | 1.30M |
| 296 | PSNL | Personalis, Inc. | 1.80B | 0.60% | 2,492,307 | 69.67M |
| 297 | INSP | Inspire Medical Systems, Inc. | 1.80B | -1.47% | 305,999 | 898.74M |
| 298 | SLBT | SL Science Holding Limited | 1.80B | -4.83% | 112,818 | 3.27M |
| 299 | SNDA | Sonida Senior Living, Inc. | 1.79B | 0.80% | 522,421 | 481.07M |
| 300 | NTLA | Intellia Therapeutics, Inc. | 1.78B | -0.63% | 2,580,280 | 59.51M |
| 301 | FTRE | Fortrea Holdings Inc. | 1.77B | 1.42% | 597,550 | 2.68B |
| 302 | BLFS | BioLife Solutions, Inc. | 1.74B | -1.09% | 700,307 | 106.69M |
| 303 | DMRA | Damora Therapeutics, Inc. | 1.73B | -0.64% | 280,007 | - |
| 304 | SEPN | Septerna, Inc. | 1.72B | -1.87% | 241,541 | 98.88M |
| 305 | ETON | Eton Pharmaceuticals, Inc. | 1.71B | -3.32% | 462,208 | 105.60M |
| 306 | NVAX | Novavax, Inc. | 1.71B | 0.19% | 5,207,142 | 413.80M |
| 307 | ANAB | AnaptysBio, Inc. | 1.70B | 2.90% | 275,249 | 232.39M |
| 308 | BRVE | Braveheart Bio, Inc. | 1.69B | -2.52% | 327,569 | - |
| 309 | AAPG | Ascentage Pharma Group International | 1.61B | 3.27% | 9,698 | 94.61M |
| 310 | OMCL | Omnicell, Inc. | 1.59B | 0.32% | 673,316 | 1.25B |
| 311 | AVLN | Avalyn Pharma Inc. | 1.57B | -0.39% | 150,880 | - |
| 312 | PAHC | Phibro Animal Health Corporation | 1.57B | -3.36% | 174,639 | 1.52B |
| 313 | XERS | Xeris Biopharma Holdings, Inc. | 1.57B | 0.12% | 1,538,577 | 335.41M |
| 314 | SDGR | Schrödinger, Inc. | 1.55B | -0.81% | 771,214 | 259.04M |
| 315 | BCAX | Bicara Therapeutics Inc. | 1.54B | -0.93% | 178,139 | - |
| 316 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | -1.46% | 337,841 | 978.38M |
| 317 | INVA | Innoviva, Inc. | 1.54B | - | 432,939 | 440.00M |
| 318 | APMD | Apnimed, Inc. | 1.54B | -0.07% | 234,128 | 120.15M |
| 319 | LBRX | LB Pharmaceuticals Inc | 1.53B | -3.96% | 282,457 | - |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.53B | 1.70% | 353,774 | - |
| 321 | TRAX | First Tracks Biotherapeutics, Inc. | 1.52B | -6.12% | 696,305 | - |
| 322 | ARDT | Ardent Health, Inc. | 1.52B | -1.37% | 509,467 | 6.41B |
| 323 | ABSI | Absci Corporation | 1.51B | - | 2,367,343 | 1.56M |
| 324 | HCSG | Healthcare Services Group, Inc. | 1.49B | -0.28% | 582,215 | 1.86B |
| 325 | TYRA | Tyra Biosciences, Inc. | 1.48B | -1.07% | 497,069 | - |
| 326 | AKTS | Aktis Oncology, Inc. | 1.48B | -1.00% | 152,348 | 10.06M |
| 327 | CNMD | CONMED Corporation | 1.48B | -0.02% | 221,725 | 1.37B |
| 328 | KMTS | Kestra Medical Technologies, Ltd. | 1.47B | -2.29% | 200,375 | 95.13M |
| 329 | ALMS | Alumis Inc. | 1.47B | 9.76% | 7,542,860 | 7.40M |
| 330 | INNV | InnovAge Holding Corp. | 1.46B | -0.37% | 122,565 | 949.17M |
| 331 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -44.03% | 27,020,426 | 717.00M |
| 332 | AGL | agilon health, inc. | 1.45B | -1.03% | 153,801 | 5.92B |
| 333 | ATEC | Alphatec Holdings, Inc. | 1.44B | 1.52% | 1,856,033 | 815.05M |
| 334 | REPL | Replimune Group, Inc. | 1.44B | -4.32% | 1,352,495 | - |
| 335 | MAZE | Maze Therapeutics, Inc. | 1.44B | -3.18% | 409,814 | 20.00M |
| 336 | HROW | Harrow, Inc. | 1.43B | -2.02% | 449,722 | 275.59M |
| 337 | VOR | Vor Biopharma Inc. | 1.43B | -2.10% | 538,761 | - |
| 338 | ANRO | Alto Neuroscience, Inc. | 1.43B | -0.66% | 241,988 | - |
| 339 | CGEM | Cullinan Therapeutics, Inc. | 1.43B | -0.76% | 384,510 | - |
| 340 | LTGO | Latigo Biotherapeutics, Inc. | 1.42B | 3.26% | 217,902 | - |
| 341 | TNDM | Tandem Diabetes Care, Inc. | 1.42B | -0.63% | 1,593,475 | 1.04B |
| 342 | OMER | Omeros Corporation | 1.38B | 1.33% | 1,165,330 | 38.42M |
| 343 | AZTA | Azenta, Inc. | 1.37B | -1.73% | 757,932 | 613.81M |
| 344 | SVRA | Savara Inc. | 1.36B | -1.65% | 963,524 | - |
| 345 | OMDA | Omada Health, Inc. | 1.36B | -4.38% | 1,369,682 | 309.76M |
| 346 | NUTX | Nutex Health Inc. | 1.35B | 2.96% | 160,572 | 846.72M |
| 347 | DRTS | Alpha Tau Medical Ltd. | 1.35B | 2.02% | 585,766 | - |
| 348 | PNTG | The Pennant Group, Inc. | 1.35B | 1.80% | 171,626 | 1.10B |
| 349 | MGTX | MeiraGTx Holdings plc | 1.34B | -0.64% | 705,750 | 397.50M |
| 350 | ORIC | ORIC Pharmaceuticals, Inc. | 1.32B | -2.97% | 547,448 | - |
| 351 | SPTX | Seaport Therapeutics, Inc. | 1.30B | -2.49% | 86,215 | - |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.29B | 0.09% | 589,829 | 3.43B |
| 353 | IMTX | Immatics N.V. | 1.29B | -0.42% | 479,013 | 47.65M |
| 354 | MLTX | MoonLake Immunotherapeutics | 1.29B | 0.86% | 794,860 | - |
| 355 | IART | Integra LifeSciences Holdings Corporation | 1.28B | -2.20% | 621,432 | 1.65B |
| 356 | MNKD | MannKind Corporation | 1.27B | -1.98% | 2,330,942 | 393.63M |
| 357 | ODTX | Odyssey Therapeutics, Inc. | 1.27B | -0.83% | 189,634 | 99.00K |
| 358 | JBIO | Jade Biosciences, Inc. | 1.26B | -7.24% | 1,250,257 | - |
| 359 | AORT | Artivion, Inc. | 1.25B | -2.73% | 438,788 | 471.47M |
| 360 | CERT | Certara, Inc. | 1.24B | -1.81% | 2,096,677 | 421.75M |
| 361 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | 3.17% | 920,093 | - |
| 362 | GLUE | Monte Rosa Therapeutics, Inc. | 1.23B | 1.13% | 672,631 | 28.73M |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | -2.73% | 860,853 | 337.34M |
| 364 | JANX | Janux Therapeutics, Inc. | 1.21B | 0.51% | 1,540,103 | 24.00M |
| 365 | BVS | Bioventus Inc. | 1.21B | -0.07% | 669,918 | 581.85M |
| 366 | GDRX | GoodRx Holdings, Inc. | 1.20B | 2.32% | 1,460,553 | 785.23M |
| 367 | OPK | OPKO Health, Inc. | 1.20B | -4.73% | 7,546,418 | 587.90M |
| 368 | CRON | Cronos Group Inc. | 1.19B | 0.62% | 1,147,499 | 179.09M |
| 369 | STAA | STAAR Surgical Company | 1.18B | 2.01% | 658,196 | 339.59M |
| 370 | TDOC | Teladoc Health, Inc. | 1.18B | 0.15% | 2,565,232 | 2.49B |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 0.51% | 164,621 | 804.27M |
| 372 | SANA | Sana Biotechnology, Inc. | 1.17B | 0.77% | 2,560,973 | - |
| 373 | KURA | Kura Oncology, Inc. | 1.17B | 0.31% | 1,464,056 | 77.23M |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 1.14B | 1.28% | 339,301 | 1.04B |
| 375 | IVA | Inventiva S.A. | 1.13B | -0.41% | 1,038,683 | 7.94M |
| 376 | ENOV | Enovis Corporation | 1.12B | -3.96% | 2,331,202 | 2.30B |
| 377 | SLDB | Solid Biosciences Inc. | 1.12B | 1.31% | 604,962 | - |
| 378 | IRMD | IRADIMED CORPORATION | 1.11B | 0.49% | 73,217 | 86.34M |
| 379 | PCRX | Pacira BioSciences, Inc. | 1.06B | 0.08% | 516,027 | 746.16M |
| 380 | OBX | Obsidian Therapeutics, Inc. | 1.06B | 0.53% | 135,043 | - |
| 381 | GMRS | GMR Solutions Inc. | 1.04B | 4.85% | 521,009 | 5.88B |
| 382 | ATTO | Attovia Therapeutics, Inc. | 1.04B | 4.63% | 192,645 | 1.35M |
| 383 | AVTX | Avalo Therapeutics, Inc. | 1.02B | -1.76% | 673,247 | 59.00K |
| 384 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.01B | 0.42% | 391,242 | 730.02M |
| 385 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.39% | 3,226,618 | 181.72M |
| 386 | FTH | Faeth Therapeutics, Inc. | 1.01B | -0.31% | 174,483 | - |
| 387 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.01B | 0.89% | 1,506,903 | 41.47M |
| 388 | CSTL | Castle Biosciences, Inc. | 997.44M | -2.30% | 170,778 | 357.28M |
| 389 | CADL | Candel Therapeutics, Inc. | 992.45M | -1.74% | 624,401 | - |
| 390 | IMMX | Immix Biopharma, Inc. | 989.39M | -0.93% | 987,179 | - |
| 391 | GERN | Geron Corporation | 970.13M | -5.03% | 14,233,152 | 204.56M |
| 392 | SGP | SpyGlass Pharma, Inc. | 969.66M | 2.51% | 82,808 | - |
| 393 | QDEL | QuidelOrtho Corporation | 955.26M | -0.14% | 836,184 | 2.67B |
| 394 | ANL | Adlai Nortye Group Ltd. | 949.87M | 6.46% | 76,917 | 18.06M |
| 395 | CBLL | CeriBell, Inc. | 942.95M | -0.97% | 330,702 | 101.96M |
| 396 | DSGN | Design Therapeutics, Inc. | 940.60M | -3.22% | 376,168 | - |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 938.85M | -0.92% | 773,315 | - |
| 398 | WVE | Wave Life Sciences, Inc. | 926.13M | -3.69% | 4,982,784 | 65.37M |
| 399 | ARDX | Ardelyx, Inc. | 924.49M | -2.37% | 2,937,836 | 450.89M |
| 400 | ANNX | Annexon, Inc. | 917.56M | -1.83% | 2,021,023 | - |
| 401 | RIGL | Rigel Pharmaceuticals, Inc. | 905.97M | -1.86% | 190,375 | 276.79M |
| 402 | BBNX | Beta Bionics, Inc. | 896.19M | 2.60% | 1,374,774 | 119.01M |
| 403 | SLN | Silence Therapeutics plc | 890.50M | - | 572,342 | 615.00K |
| 404 | TBPH | Theravance Biopharma, Inc. | 886.77M | 0.06% | 301,864 | 104.31M |
| 405 | ACRS | Aclaris Therapeutics, Inc. | 875.83M | -3.72% | 1,391,978 | 8.22M |
| 406 | CBIO | Crescent Biopharma, Inc. | 873.14M | 10.03% | 772,995 | 11.88M |
| 407 | HSTM | HealthStream, Inc. | 869.60M | -0.10% | 192,321 | 321.12M |
| 408 | HELP | Cybin Inc. | 859.92M | -1.51% | 820,312 | - |
| 409 | AHCO | AdaptHealth Corp. | 856.49M | 6.29% | 3,208,632 | 3.36B |
| 410 | ACHV | Achieve Life Sciences, Inc. | 855.12M | -2.00% | 1,420,680 | - |
| 411 | INMD | InMode Ltd. | 853.01M | -0.74% | 286,505 | 374.63M |
| 412 | AVR | Anteris Technologies Global Corp. | 849.84M | 1.51% | 533,385 | 2.24M |
| 413 | CLYM | Climb Bio, Inc. | 837.99M | -3.06% | 5,388,317 | - |
| 414 | SIBN | SI-BONE, Inc. | 835.42M | -2.71% | 525,122 | 213.60M |
| 415 | DBVT | DBV Technologies S.A. | 813.73M | 0.66% | 144,931 | 5.04M |
| 416 | FDMT | 4D Molecular Therapeutics, Inc. | 812.09M | -1.61% | 455,790 | 92.01M |
| 417 | GLAS | Glass House Brands Inc. | 810.49M | 0.58% | 556,486 | 176.98M |
| 418 | CTMX | CytomX Therapeutics, Inc. | 801.87M | -1.08% | 2,556,815 | 18.30M |
| 419 | PHAR | Pharming Group N.V. | 800.74M | 2.32% | 5,187 | 366.48M |
| 420 | MNPR | Monopar Therapeutics Inc. | 795.73M | 1.95% | 197,292 | - |
| 421 | NVCT | Nuvectis Pharma, Inc. | 794.01M | 1.88% | 135,961 | - |
| 422 | VREX | Varex Imaging Corporation | 780.58M | 0.27% | 1,091,723 | 865.00M |
| 423 | COLL | Collegium Pharmaceutical, Inc. | 771.57M | -2.47% | 843,121 | 808.21M |
| 424 | AURA | Aura Biosciences, Inc. | 764.30M | -1.73% | 875,865 | - |
| 425 | NGNE | Neurogene Inc. | 752.63M | -1.96% | 255,187 | 925.00K |
| 426 | OCS | Oculis Holding AG | 751.28M | 1.25% | 178,351 | 1.45M |
| 427 | AHG | Akso Health Group | 748.59M | 2.80% | 11,357 | 13.83M |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 744.67M | 1.95% | 722,153 | 136.07M |
| 429 | ASMB | Assembly Biosciences, Inc. | 735.63M | -1.61% | 224,936 | 74.85M |
| 430 | AGMB | AgomAb Therapeutics NV | 730.35M | 8.57% | 407,866 | - |
| 431 | MPLT | MapLight Therapeutics, Inc. | 730.26M | 0.61% | 790,789 | - |
| 432 | VSTM | Verastem, Inc. | 722.70M | -0.50% | 2,396,492 | 87.53M |
| 433 | PHAT | Phathom Pharmaceuticals, Inc. | 718.84M | -2.27% | 663,054 | 239.66M |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 713.55M | 0.11% | 139,210 | - |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 708.88M | -2.72% | 911,528 | 389.32M |
| 436 | SOPH | SOPHiA GENETICS SA | 706.56M | 0.24% | 669,285 | 86.17M |
| 437 | DRUG | Bright Minds Biosciences Inc. | 705.94M | -4.36% | 124,062 | - |
| 438 | STTK | Shattuck Labs, Inc. | 698.53M | 0.72% | 563,423 | 1.00M |
| 439 | OABI | OmniAb, Inc. | 690.60M | -5.75% | 2,003,687 | 38.46M |
| 440 | PHR | Phreesia, Inc. | 686.11M | -6.33% | 1,261,122 | 507.79M |
| 441 | ALLO | Allogene Therapeutics, Inc. | 684.07M | - | 4,419,186 | 4.64M |
| 442 | GYRE | Gyre Therapeutics, Inc. | 682.86M | 1.26% | 41,192 | 109.82M |
| 443 | SSII | SS Innovations International, Inc. | 679.31M | -0.29% | 48,331 | 52.40M |
| 444 | SGMT | Sagimet Biosciences Inc. | 678.77M | -0.64% | 1,141,909 | - |
| 445 | EVO | Evotec SE | 676.37M | - | 92,845 | 819.47M |
| 446 | AQST | Aquestive Therapeutics, Inc. | 671.49M | -0.56% | 1,588,149 | 54.09M |
| 447 | VALN | Valneva SE | 664.34M | -0.84% | 40,135 | 163.30M |
| 448 | CTEV | Claritev Corporation | 662.48M | -2.83% | 73,387 | 994.67M |
| 449 | CTNM | Contineum Therapeutics, Inc. | 661.00M | 1.91% | 278,612 | - |
| 450 | CRMD | CorMedix Inc. | 660.19M | -1.63% | 706,670 | 462.25M |
| 451 | PRME | Prime Medicine, Inc. | 660.02M | 1.09% | 2,298,137 | 4.07M |
| 452 | MDXG | MiMedx Group, Inc. | 645.72M | -2.64% | 720,122 | 355.17M |
| 453 | ANGO | AngioDynamics, Inc. | 639.41M | -0.96% | 438,276 | 320.17M |
| 454 | ALT | Altimmune, Inc. | 628.29M | -1.52% | 2,528,911 | 31.00K |
| 455 | TLRY | Tilray Brands, Inc. | 614.33M | 0.22% | 3,617,971 | 915.45M |
| 456 | BLSM | BlossomHill Therapeutics, Inc. | 613.49M | 3.30% | 90,359 | - |
| 457 | CTKB | Cytek Biosciences, Inc. | 610.92M | 0.21% | 485,222 | 206.71M |
| 458 | AUTL | Autolus Therapeutics plc | 609.51M | 2.23% | 1,694,235 | 117.39M |
| 459 | ARVN | Arvinas, Inc. | 608.75M | -2.92% | 501,371 | 316.70M |
| 460 | STLN | Starling Oncology, Inc. | 608.44M | -1.97% | 660,864 | 587.24M |
| 461 | RGNX | REGENXBIO Inc. | 607.32M | -4.17% | 839,150 | 174.48M |
| 462 | EOLS | Evolus, Inc. | 597.76M | -0.11% | 733,275 | 316.49M |
| 463 | EIKN | Eikon Therapeutics, Inc. | 593.65M | -3.69% | 384,275 | - |
| 464 | CABA | Cabaletta Bio, Inc. | 590.02M | -2.52% | 7,433,535 | - |
| 465 | KIDS | OrthoPediatrics Corp. | 589.82M | -0.92% | 126,630 | 252.72M |
| 466 | WEAV | Weave Communications, Inc. | 586.39M | 0.27% | 2,327,483 | 257.79M |
| 467 | TECX | Tectonic Therapeutic, Inc. | 584.92M | -1.51% | 114,690 | - |
| 468 | SCTX | Scribe Therapeutics Inc. | 581.21M | -0.29% | 147,961 | 36.28M |
| 469 | PROK | ProKidney Corp. | 580.46M | 0.52% | 695,185 | 818.00K |
| 470 | BWAY | BrainsWay Ltd. | 574.80M | 1.61% | 59,752 | 60.70M |
| 471 | DCTH | Delcath Systems, Inc. | 571.84M | -0.60% | 268,643 | 95.42M |
| 472 | SPRY | ARS Pharmaceuticals, Inc. | 563.87M | -2.58% | 1,088,136 | 116.93M |
| 473 | ZURA | Zura Bio Limited | 563.48M | 3.70% | 1,679,226 | - |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 543.90M | -1.64% | 310,302 | 251.00K |
| 475 | OVID | Ovid Therapeutics Inc. | 542.93M | 2.58% | 1,358,051 | 1.58M |
| 476 | PRLD | Prelude Therapeutics Incorporated | 540.72M | -3.31% | 534,240 | 22.42M |
| 477 | FLGT | Fulgent Genetics, Inc. | 540.68M | -1.95% | 245,482 | 323.93M |
| 478 | CAPR | Capricor Therapeutics, Inc. | 539.53M | -6.17% | 3,736,407 | 11.13M |
| 479 | SENS | Senseonics Holdings, Inc. | 523.45M | -0.40% | 692,829 | 48.55M |
| 480 | CERS | Cerus Corporation | 517.92M | -1.15% | 798,688 | 221.55M |
| 481 | KYTX | Kyverna Therapeutics, Inc. | 516.39M | -3.08% | 594,709 | - |
| 482 | ENTX | Entera Bio Ltd. | 510.77M | 1.03% | 126,638 | 42.00K |
| 483 | NPCE | NeuroPace, Inc. | 506.28M | -2.90% | 141,482 | 106.99M |
| 484 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 485 | TCMD | Tactile Systems Technology, Inc. | 498.58M | -1.78% | 296,754 | 350.31M |
| 486 | PRTA | Prothena Corporation plc | 492.83M | -0.88% | 275,198 | 54.53M |
| 487 | EPRX | Eupraxia Pharmaceuticals Inc. | 490.48M | 0.67% | 392,778 | - |
| 488 | PBYI | Puma Biotechnology, Inc. | 485.74M | -2.89% | 244,233 | 231.24M |
| 489 | EVH | Evolent Health, Inc. | 481.63M | 0.71% | 1,629,597 | 2.10B |
| 490 | KMDA | Kamada Ltd. | 475.76M | -1.79% | 112,126 | 191.85M |
| 491 | SRTA | Strata Critical Medical, Inc. | 475.07M | -0.37% | 756,748 | 255.98M |
| 492 | RZLT | Rezolute, Inc. | 474.28M | -0.44% | 771,626 | - |
| 493 | EDIT | Editas Medicine, Inc. | 473.03M | - | 1,378,045 | 47.01M |
| 494 | NRC | NRC Health | 470.04M | 6.20% | 146,449 | 140.00M |
| 495 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.01M | -1.14% | 736,329 | 132.42M |
| 496 | AVIR | Atea Pharmaceuticals, Inc. | 466.79M | 2.11% | 198,519 | - |
| 497 | RLMD | Relmada Therapeutics, Inc. | 466.15M | -3.74% | 847,487 | - |
| 498 | SGHT | Sight Sciences, Inc. | 461.64M | -0.48% | 93,644 | 83.38M |
| 499 | CCCC | C4 Therapeutics, Inc. | 460.11M | -1.32% | 2,069,393 | 35.04M |
| 500 | IKT | Inhibikase Therapeutics, Inc. | 458.83M | 0.80% | 564,201 | 1.00 |